- Issuer ticker
-
PMVP
- Reported as of
-
11 Jun 2021
- Net transaction value
-
-$2,257,955
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
15 Jun 2021, 18:58:19 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Joseph Cosmai - Euclidean Capital LLC, By: Joseph Cosmai, Manager
Key filing fact
Euclidean Capital LLC filed Form 4 for PMV Pharmaceuticals, Inc. (PMVP) on 15 Jun 2021.
Key facts
- This page summarizes Euclidean Capital LLC's Form 4 filing for PMV Pharmaceuticals, Inc. (PMVP).
- 10 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 15 Jun 2021, 18:58.
Change
- Previous filing in this sequence was filed on 11 Jun 2021.
- Current net transaction value: -$2,257,955.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PMVP
transaction
Common Stock
Sale
- Transaction value
- $78,551
- Shares
- -2,324
- Change %
- -0.48%
- Price
-
$33.80
- Shares after
- 479,062
- Date
- 11 Jun 2021
- Ownership
- See Footnotes
- Footnotes
- F1, F6
PMVP
transaction
Common Stock
Sale
- Transaction value
- $110,256
- Shares
- -3,262
- Change %
- -0.48%
- Price
-
$33.80
- Shares after
- 672,289
- Date
- 11 Jun 2021
- Ownership
- See Footnotes
- Footnotes
- F2, F6
PMVP
transaction
Common Stock
Sale
- Transaction value
- $119,415
- Shares
- -3,533
- Change %
- -0.48%
- Price
-
$33.80
- Shares after
- 728,140
- Date
- 11 Jun 2021
- Ownership
- See Footnotes
- Footnotes
- F3, F6
PMVP
transaction
Common Stock
Sale
- Transaction value
- $413,611
- Shares
- -12,237
- Change %
- -0.48%
- Price
-
$33.80
- Shares after
- 2,521,280
- Date
- 11 Jun 2021
- Ownership
- See Footnotes
- Footnotes
- F4, F6
PMVP
transaction
Common Stock
Sale
- Transaction value
- $20,990
- Shares
- -621
- Change %
- -0.48%
- Price
-
$33.80
- Shares after
- 128,359
- Date
- 11 Jun 2021
- Ownership
- See Footnotes
- Footnotes
- F5, F6
PMVP
transaction
Common Stock
Sale
- Transaction value
- $160,283
- Shares
- -4,699
- Change %
- -0.98%
- Price
-
$34.11
- Shares after
- 474,363
- Date
- 14 Jun 2021
- Ownership
- See Footnotes
- Footnotes
- F1, F6
PMVP
transaction
Common Stock
Sale
- Transaction value
- $224,887
- Shares
- -6,593
- Change %
- -0.98%
- Price
-
$34.11
- Shares after
- 665,696
- Date
- 14 Jun 2021
- Ownership
- See Footnotes
- Footnotes
- F2, F6
PMVP
transaction
Common Stock
Sale
- Transaction value
- $243,580
- Shares
- -7,141
- Change %
- -0.98%
- Price
-
$34.11
- Shares after
- 720,999
- Date
- 14 Jun 2021
- Ownership
- See Footnotes
- Footnotes
- F3, F6
PMVP
transaction
Common Stock
Sale
- Transaction value
- $843,404
- Shares
- -24,726
- Change %
- -0.98%
- Price
-
$34.11
- Shares after
- 2,496,554
- Date
- 14 Jun 2021
- Ownership
- See Footnotes
- Footnotes
- F4, F6
PMVP
transaction
Common Stock
Sale
- Transaction value
- $42,979
- Shares
- -1,260
- Change %
- -0.98%
- Price
-
$34.11
- Shares after
- 127,099
- Date
- 14 Jun 2021
- Ownership
- See Footnotes
- Footnotes
- F5, F6
* marks a reported price that did not pass the local price check.
Section 16 status
Euclidean Capital LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses
6 footnotes